Menu
Back to User profile » Dr Tie-Li Zhou
Papers published by Dr Tie-Li Zhou:
Glabridin Functions as a Quorum Sensing Inhibitor to Inhibit Biofilm Formation and Swarming Motility of Multidrug-Resistant Acinetobacter baumannii
Lin H, Zhou C, Yu KH, Lin YS, Wang LB, Zhang Y, Liu SX, Xu WY, Sun Y, Zhou TL, Cao JM, Ye JZ
Infection and Drug Resistance 2023, 16:5697-5705
Published Date: 30 August 2023
Emergence of Ceftazidime–Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment
Xu M, Qian C, Jia H, Feng L, Shi S, Zhang Y, Wang L, Cao J, Zhou T, Zhou C
Infection and Drug Resistance 2022, 15:6881-6891
Published Date: 28 November 2022
Novel Insight of Transcription Factor PtrA on Pathogenicity and Carbapenems Resistance in Pseudomonas aeruginosa
Zhang Y, Wang L, Chen L, Zhu P, Huang N, Chen T, Chen L, Wang Z, Liao W, Cao J, Zhou T
Infection and Drug Resistance 2022, 15:4213-4227
Published Date: 4 August 2022
Comparison of Anti-Microbic and Anti-Biofilm Activity Among Tedizolid and Radezolid Against Linezolid-Resistant Enterococcus faecalis Isolates
Wang L, Zhang Y, Liu S, Huang N, Zeng W, Xu W, Zhou T, Shen M
Infection and Drug Resistance 2021, 14:4619-4627
Published Date: 5 November 2021
Outbreak of Multidrug-Resistant OXA-232-Producing ST15 Klebsiella pneumoniae in a Teaching Hospital in Wenzhou, China
Jia H, Zhang Y, Ye J, Xu W, Xu Y, Zeng W, Liao W, Chen T, Cao J, Wu Q, Zhou T
Infection and Drug Resistance 2021, 14:4395-4407
Published Date: 24 October 2021
Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Enterobacter cloacae Complex Isolated from Chinese Patients During 2004–2018
Liu S, Huang N, Zhou C, Lin Y, Zhang Y, Wang L, Zheng X, Zhou T, Wang Z
Infection and Drug Resistance 2021, 14:3647-3658
Published Date: 7 September 2021
In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China
Huang N, Chen T, Chen L, Zhang Y, Lin Y, Zheng X, Zhou T, Chen L
Infection and Drug Resistance 2021, 14:2499-2507
Published Date: 30 June 2021
Synergistic Activity and Biofilm Formation Effect of Colistin Combined with PFK-158 Against Colistin-Resistant Gram-Negative Bacteria
Chen L, Yu K, Chen L, Zheng X, Huang N, Lin Y, Jia H, Liao W, Cao J, Zhou T
Infection and Drug Resistance 2021, 14:2143-2154
Published Date: 9 June 2021
Unraveling Mechanisms and Epidemic Characteristics of Nitrofurantoin Resistance in Uropathogenic Enterococcus faecium Clinical Isolates
Zhang Y, Wang L, Zhou C, Lin Y, Liu S, Zeng W, Yu K, Zhou T, Cao J
Infection and Drug Resistance 2021, 14:1601-1611
Published Date: 22 April 2021
Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
Zheng X, Fang R, Wang C, Tian X, Lin J, Zeng W, Zhou T, Xu C
Infection and Drug Resistance 2021, 14:1527-1536
Published Date: 21 April 2021
Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China
Liao W, Lin J, Jia H, Zhou C, Zhang Y, Lin Y, Ye J, Cao J, Zhou T
Infection and Drug Resistance 2020, 13:3551-3561
Published Date: 9 October 2020
Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
Xu Y, Zheng X, Zeng W, Chen T, Liao W, Qian J, Lin J, Zhou C, Tian X, Cao J, Zhou T
Infection and Drug Resistance 2020, 13:1419-1428
Published Date: 14 May 2020
Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016
Zhao Y, Zhang S, Fang R, Wu Q, Li J, Zhang Y, Rocker A, Cao J, Lithgow T, Zhou T
Infection and Drug Resistance 2020, 13:931-940
Published Date: 31 March 2020
Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Escherichia coli Isolated from Chinese Patients During 2002–2017
Tian X, Zheng X, Sun Y, Fang R, Zhang S, Zhang X, Lin J, Cao J, Zhou T
Infection and Drug Resistance 2020, 13:501-512
Published Date: 17 February 2020